Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
- M. Steinberg, F. Barton, +24 authors M. Terrin
- Medicine
- JAMA
- 2 April 2003
CONTEXT
Hydroxyurea increases levels of fetal hemoglobin (HbF) and decreases morbidity from vaso-occlusive complications in patients with sickle cell anemia (SCA). High HbF levels reduce morbidity… Expand
The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up
- M. Steinberg, W. Mccarthy, +8 authors M. Waclawiw
- Medicine
- American journal of hematology
- 1 June 2010
A randomized, controlled clinical trial established the efficacy and safety of short‐term use of hydroxyurea in adult sickle cell anemia. To examine the risks and benefits of long‐term hydroxyurea… Expand
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.
- E. Klings, R. Machado, +17 authors M. Gladwin
- Medicine
- American journal of respiratory and critical care…
- 15 March 2014
BACKGROUND
In adults with sickle cell disease (SCD), an increased tricuspid regurgitant velocity (TRV) measured by Doppler echocardiography, an increased serum N-terminal pro-brain natriuretic… Expand
Religiosity/Spirituality and Pain in Patients With Sickle Cell Disease
- M. Harrison, C. Edwards, H. Koenig, H. Bosworth, L. Decastro, Mary Wood
- Medicine
- The Journal of nervous and mental disease
- 1 April 2005
Religion/spirituality has been identified by individuals with sickle cell disease (SCD) as an important factor in coping with stress and in determining quality of life. Research has demonstrated… Expand
Moderate chronic pain, weight and dietary intake in African-American adult patients with sickle cell disease.
- J. Pells, K. Presnell, +14 authors E. Robinson
- Medicine
- Journal of the National Medical Association
- 1 December 2005
In this exploratory study, we evaluated weight status and dietary intake patterns during painful episodes in adult patients with SCD. Specifically, we explored the relation between pain severity and… Expand
Depression, suicidal ideation, and attempts in black patients with sickle cell disease.
- C. Edwards, M. Green, +16 authors J. McNeil
- Medicine
- Journal of the National Medical Association
- 1 November 2009
There is a strong relationship between suicidal ideation, suicide attempts, and depression. Rates of successful suicides are relatively high among the chronically ill compared to other populations… Expand
The association of optimism and perceived discrimination with health care utilization in adults with sickle cell disease.
- Michael V Stanton, C. Jonassaint, +4 authors R. Williams
- Medicine
- Journal of the National Medical Association
- 1 November 2010
OBJECTIVE
We evaluated the effect of perceived discrimination, optimism, and their interaction on health care utilization among African American adults with sickle cell disease (SCD).
METHODS… Expand
Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible.
- T. Batiuk, F. Pazderka, J. Enns, L. Decastro, P. Halloran
- Biology, Medicine
- The Journal of clinical investigation
- 1 September 1995
Despite increasing information about the mechanism of action of cyclosporine A (CsA), little is known about the way lymphocytes recover from CsA. Recovery is central to understanding the… Expand
Differences in platelet alpha-granule release between normals and immune thrombocytopenic patients and between young and old platelets.
- H. Rinder, J. Tracey, +4 authors B. R. Smith
- Medicine
- Thrombosis and haemostasis
- 1 September 1998
The risk of serious bleeding in patients with immune thrombocytopenic purpura (ITP) appears to be less than in comparably thrombocytopenic patients with megakaryocytic hypoplasia. It has been… Expand
Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia.
- S. Ballas, W. Mccarthy, +4 authors M. Waclawiw
- Medicine
- Journal of the National Medical Association
- 1 October 2009
The Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH) was a randomized double-blind placebo-controlled trial to test whether hydroxyurea could reduce the rate of painful crises in adults… Expand